You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

899 Results
Document
Feb 2023
Document
Mar 2023
Document
Mar 2023
Regimen
Cancer Type:
Endocrine, 
Pancreatic Neuroendocrine, 
Genitourinary, 
Renal cell / Kidney
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Funding:
Exceptional Access Program
    Belzutifan – For the treatment of adult patients with von Hippel-Lindau (VHL) disease, based on criteria
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
belzutifan
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Jun 2025
Document
Apr 2023
Document
Apr 2023
Drug
Other Name(s): Mektovi®
Quick Link(s):
Drug Monograph, Patient Info Sheet
Jul 2023
Document
May 2023
Document
May 2023
Document
May 2023
Document
Jun 2023

Pages